A recent Supreme Court ruling that allows drug makers to ignore rivals' patents in conducting animal research and clinical trials, but failed to address research tools used to study those drugs, should be a relief for some San Diego-based biotech companies, according to a local attorney...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99